Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients between 40 and 80 years of age with controlled COPD.
Women must be surgically sterilized or postmenopausal. Additional birth control and post-menopausal information will be available at time of enrollment.
Body mass index (BMI) must be within the range of 18 to 32 kg/m2
You may not be if
Participation in any interventional clinical investigation with 4 weeks of study start
Blood loss or donation of 400 mL or more within 2 months of study start Significant illness (other than respiratory) within 2 weeks of study start
Past medical personal or close family history of clinically significant ECG abnormalities
Any medical condition that may interfere with exercise testing or that may make spirometry unsafe
A known hypersensitivity to the drug.
History of immunocompromise, including a positive HIV test result.
History of drug or alcohol abuse within 12 months of study start
Any condition that may compromise patient safety
Clareo Health | Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease
